Compass Therapeutics (CMPX) Accounts Payables (2018 - 2026)
Compass Therapeutics (CMPX) posted Accounts Payables of $906000.0 for Q1 2026, down 42.84% sequentially from $1.6 million in Q4 2025, and down 42.55% YoY from $1.6 million in Q1 2025.
Compass Therapeutics (CMPX) Accounts Payables (2018 - 2026) Analysis & Trends
Compass Therapeutics has reported Accounts Payables for 9 years, with the latest figure at $906000.0 in Q1 2026.
- Quarterly Accounts Payables fell 42.55% year-over-year to $906000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $906000.0 (down 42.55% YoY) and the FY2025 annual result came in at $1.6 million, down 29.52% from the prior year.
- Accounts Payables declined to $906000.0 in Q1 2026 per CMPX's latest filing, from $1.6 million in the prior quarter.
- Over five years, Accounts Payables peaked at $6.5 million in Q2 2022 and troughed at $257000.0 in Q1 2022.
- A 5-year average of $2.1 million and a median of $1.6 million in 2025 frame the typical range for Accounts Payables.
- The widest YoY moves for Accounts Payables: up 337.74% in 2023, down 88.92% in 2023.
- Over 5 years, Accounts Payables stood at $3.4 million in 2022, then climbed by 20.93% to $4.1 million in 2023, then slumped by 45.01% to $2.2 million in 2024, then decreased by 29.52% to $1.6 million in 2025, then tumbled by 42.84% to $906000.0 in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $906000.0, $1.6 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - | 2.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.91 Mn |
| Mar 31, 2026 | 906,000.00 |
| Dec 31, 2025 | 1.59 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 960,000.00 |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 854,000.00 |
| Dec 31, 2023 | 4.09 Mn |
| Sep 30, 2023 | 2.31 Mn |
| Jun 30, 2023 | 724,000.00 |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 3.38 Mn |
| Sep 30, 2022 | 2.76 Mn |
| Jun 30, 2022 | 6.53 Mn |
| Mar 31, 2022 | 257,000.00 |
| Dec 31, 2021 | 867,000.00 |
| Sep 30, 2021 | 868,000.00 |